See more : Esperion Therapeutics, Inc. (ESPR) Income Statement Analysis – Financial Results
Complete financial analysis of Quantum-Si incorporated (QSI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quantum-Si incorporated, a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Q-Interline A/S (QINTER.CO) Income Statement Analysis – Financial Results
- TS Lines Ltd (2510.HK) Income Statement Analysis – Financial Results
- Sumitomo Rubber Industries, Ltd. (5110.T) Income Statement Analysis – Financial Results
- Wellbeing Digital Sciences Inc. (MEDI.NE) Income Statement Analysis – Financial Results
- Wanshih Electronic Co., Ltd. (6134.TWO) Income Statement Analysis – Financial Results
Quantum-Si incorporated (QSI)
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.08M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 594.00K | 2.58M | 1.04M | 894.00K | 0.00 |
| Gross Profit | 488.00K | -2.58M | -1.04M | -894.00K | 0.00 |
| Gross Profit Ratio | 45.10% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 67.03M | 72.06M | 46.58M | 27.56M | 28.10M |
| General & Administrative | 42.81M | 42.29M | 46.38M | 7.98M | 7.88M |
| Selling & Marketing | 400.00K | 7.00K | 3.96M | 1.15M | 634.00K |
| SG&A | 44.63M | 42.30M | 50.33M | 9.14M | 8.52M |
| Other Expenses | 0.00 | -20.15M | -5.00M | -10.00K | 5.00K |
| Operating Expenses | 111.66M | 114.36M | 96.91M | 36.69M | 36.62M |
| Cost & Expenses | 112.25M | 114.36M | 96.91M | 36.69M | 36.62M |
| Interest Income | 0.00 | 0.00 | 2.54M | 88.00K | 823.00K |
| Interest Expense | 0.00 | 0.00 | 5.00K | 9.00K | 0.00 |
| Depreciation & Amortization | 4.16M | 2.58M | 1.04M | 894.00K | 780.00K |
| EBITDA | -91.80M | -129.86M | -95.87M | -35.80M | -35.84M |
| EBITDA Ratio | -8,484.66% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -111.17M | -123.84M | -96.91M | -36.69M | -36.62M |
| Operating Income Ratio | -10,274.58% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 15.21M | -8.60M | 1.92M | 78.00K | 828.00K |
| Income Before Tax | -95.96M | -132.44M | -94.99M | -36.61M | -35.79M |
| Income Before Tax Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 8.60M | -6.04M | -1.00K | 5.00K |
| Net Income | -95.96M | -141.04M | -88.95M | -36.61M | -35.80M |
| Net Income Ratio | -8,868.76% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
| EPS Diluted | -0.68 | -1.01 | -1.12 | -6.81 | -0.26 |
| Weighted Avg Shares Out | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
| Weighted Avg Shares Out (Dil) | 141.30M | 139.26M | 79.58M | 5.38M | 136.40M |
Lab Instrument Industry Update - New Commercial Entrants
Lab Instrument and Services providers in the healthcare industry can generate high recurring revenues. Many loss-making instrument makers in the industry may not provide meaningful returns and carry high risks. Cytek stands out as the best opportunity in the sector...
Quantum-Si Incorporated (QSI) Q1 2024 Earnings Call Transcript
Quantum-Si Incorporated (NASDAQ:QSI ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Katherine Atkinson - Senior Vice President-Commercial Marketing Jeff Hawkins - President and Chief Executive Officer Jeff Keyes - Chief Financial Officer Conference Call...
Quantum-Si Reports First Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter ended March 31, 2024. Press Release Highlights Reported revenue of $457,000 in the first quarter of 2024...
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Software to reduce processing time and increase output and precision of Next-Generation Protein Sequencing™ (NGPS) data from the...
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024.
Penny Stock Quantum-Si Incorporated Readies For Lift-Off
Penny stocks are a dime a dozen and come with as much risk because their businesses are unproven; Quantum-Si Incorporated NASDAQ: QSI is not a run-of-the-mill penny stock. Quantum-Si Incorporated manufactures, markets, and supports the Platinum protein sequencer.
Penny Stock Quantum-Si Incorporated Readies For Lift-Off
Penny stocks are a dime a dozen and come with as much risk because their businesses are unproven; Quantum-Si Incorporated NASDAQ: QSI is not a run-of-the-mill penny stock. Quantum-Si Incorporated manufactures, markets, and supports the Platinum protein sequencer.
Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries,...
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (NASDAQ: QSI): WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated, will showcase its Next-Generation Protein Sequencing™ instrument, Platinum®, and recent enhancements at the 20th Anniversary US HUPO Conference in Portland, Oregon on March 9-13. Additionally, researchers will...
Quantum-Si Incorporated (QSI) Q4 2023 Earnings Call Transcript
Quantum-Si Incorporated (QSI) Q4 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports